Cardiol Therapeutics
Cardiol Therapeutics is a clinical-stage biotechnology company focused on the research and development of innovative therapies for heart diseases and related inflammatory conditions. The company leverages advanced science to develop pharmaceutical products targeting cardiovascular health, with an emphasis on addressing unmet medical needs in acute and chronic heart failure. Cardiol Therapeutics’ lead product candidates are designed to improve patient outcomes through novel mechanisms of action. With a commitment to rigorous clinical research and regulatory compliance, Cardiol Therapeutics aims to advance cardiovascular medicine and enhance quality of life for patients worldwide. The company collaborates with leading medical institutions to drive innovation in the treatment of heart disease.
